How big is Asklepion Pharmaceuticals' plan?

Asklepion Pharmaceuticals' plan reported $902K in assets and 7 participants for 2024.

Original filing (PDF)20251006152040NAL0002002707001

Asklepion Pharmaceuticals

Name: Asklepion Pharmaceuticals — Asklepion 401(k) Plan, Form 5500 (2024)
Creator: Asklepion Pharmaceuticals
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Asklepion 401(k) Plan

401(k) retirement plan · Asklepion Pharmaceuticals' Asklepion 401(k) Plan held $902K in plan assets for 7 participants in 2024.

Active participants

Accounts w/ balance

Plan assets (EOY)

$902K

Net assets (EOY)

$902K

People on this filing

TINA Blair signed Asklepion Pharmaceuticals' 2024 Form 5500 as plan administrator.

TINA Blair — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Asklepion Pharmaceuticals' EIN is 20-5208658.

EIN 20-5208658

Plan number 001

Plan year 2024

ACK ID 20251006152040NAL0002002707001

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for Asklepion Pharmaceuticals from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

Asklepion Pharmaceuticals' plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ASKLEPION PHARMACEUTICALS.

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
High account-holder ratio — balance-holders per active participant in the top 15% of peers (96th percentile).

Plan sponsor

Name

ASKLEPION PHARMACEUTICALS

EIN

all filings

Address

729 EAST PRATT STREET · SUITE 360 · BALTIMORE, MD · 21202

Phone

(443) 226-1715

Industry

Professional & Technical Services

Plan administrator